Alnylam Pharmaceuticals Inc (ALNY)
245.94
-2.85
(-1.15%)
USD |
NASDAQ |
Nov 21, 14:58
Alnylam Pharmaceuticals Price: 245.94 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 235.78 | 249.10 | 234.43 | 248.79 | 1.041M |
| Nov 19, 2024 | 232.19 | 235.94 | 231.23 | 234.27 | 830851.0 |
| Nov 18, 2024 | 235.80 | 242.49 | 229.86 | 232.27 | 1.562M |
| Nov 15, 2024 | 253.11 | 254.17 | 234.88 | 235.56 | 1.761M |
| Nov 14, 2024 | 262.18 | 262.82 | 256.75 | 257.91 | 648243.0 |
| Nov 13, 2024 | 269.20 | 271.08 | 264.31 | 264.60 | 651061.0 |
| Nov 12, 2024 | 268.22 | 270.77 | 264.11 | 268.95 | 1.089M |
| Nov 11, 2024 | 276.10 | 286.58 | 276.10 | 279.82 | 907136.0 |
| Nov 08, 2024 | 271.63 | 279.50 | 270.98 | 277.43 | 848533.0 |
| Nov 07, 2024 | 273.01 | 275.07 | 270.04 | 272.22 | 607443.0 |
| Nov 06, 2024 | 266.21 | 278.21 | 265.52 | 273.01 | 1.377M |
| Nov 05, 2024 | 268.47 | 268.89 | 264.23 | 265.29 | 970282.0 |
| Nov 04, 2024 | 268.82 | 272.92 | 263.67 | 269.95 | 781879.0 |
| Nov 01, 2024 | 267.05 | 274.03 | 264.00 | 273.91 | 866294.0 |
| Oct 31, 2024 | 275.41 | 276.00 | 263.65 | 266.59 | 1.573M |
| Oct 30, 2024 | 284.10 | 287.87 | 281.39 | 281.49 | 976405.0 |
| Oct 29, 2024 | 285.93 | 287.02 | 282.22 | 284.69 | 701870.0 |
| Oct 28, 2024 | 288.35 | 290.94 | 285.84 | 286.91 | 521372.0 |
| Oct 25, 2024 | 293.69 | 293.74 | 283.78 | 284.86 | 1.169M |
| Oct 24, 2024 | 293.92 | 301.04 | 293.45 | 293.69 | 626725.0 |
| Oct 23, 2024 | 296.48 | 299.17 | 292.20 | 294.87 | 578713.0 |
| Oct 22, 2024 | 292.10 | 297.50 | 291.90 | 296.48 | 447936.0 |
| Oct 21, 2024 | 294.33 | 295.38 | 288.34 | 292.01 | 1.382M |
| Oct 18, 2024 | 296.01 | 298.94 | 295.51 | 295.93 | 968699.0 |
| Oct 17, 2024 | 299.15 | 304.39 | 296.59 | 296.75 | 1.205M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
93.12
Minimum
Mar 12 2020
300.55
Maximum
Oct 16 2024
173.11
Average
165.24
Median
Mar 30 2022
Price Benchmarks
| Pfizer Inc | 24.93 |
| BridgeBio Pharma Inc | 23.31 |
| Gilead Sciences Inc | 89.44 |
| Johnson & Johnson | 155.82 |
| Regeneron Pharmaceuticals Inc | 745.83 |
Price Related Metrics
| PS Ratio | 14.88 |
| Price to Book Value | 980.45 |
| Price to Free Cash Flow | 1940.99 |
| Earnings Yield | -1.07% |
| Market Cap | 31.72B |